Emergent Biosolutions Inc. buy Benchmark Co.
Start price
07.03.24
/
50%
€2.53
Target price
07.03.25
€4.58
Performance (%)
-28.76%
Price
26.04.24
€1.80
Summary
This prediction is currently active. The prediction for Emergent Biosolutions Inc. disappoints with a performance of -28.76%. This prediction currently runs until 07.03.25. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Emergent Biosolutions Inc. | -5.785% | -5.785% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
Comments by Benchmark_Co_ for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock.
Ratings data for EBS provided by MarketBeat
Stopped prediction by Benchmark_Co_ for Emergent Biosolutions Inc.
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€2.04
11.04.24
11.04.24
€4.65
11.04.25
11.04.25
-11.79%
26.04.24
26.04.24
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€11.36
10.04.23
10.04.23
€20.27
10.04.24
10.04.24
-82.04%
11.04.24
11.04.24